The protective role of anti‐parkinsonian drugs in pancreatic cancer risk: A comprehensive case–control study in Taiwan
Cancer Science · 2025
DOI: 10.1111/cas.16422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Hsuan-Chia Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Antiparkinson Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Pancreatic cancer is among the deadliest cancers, with a grim prognosis despite advances in treatment. We conducted a population‐based case–control study from Taiwan, linking Health and Welfare Data Science Center data to the Taiwan Cancer Registry, which offers a promising strategy for its treatment through drug repurposing. The study aims to identify the association of anti‐parkinsonian drugs with pancreatic cancer risk across different age groups. The analysis encompassed 18,921 pancreatic cancer cases and 75,684 matched controls, employing conditional logistic regression to assess the impact of anti‐parkinsonian drugs on the risk of pancreatic cancer. Key findings revealed a statistically significant association of the administration with specific anti‐parkinsonian medications, including anticholinergic agents, tertiary amines, dopa derivatives, and dopamine receptor agonists, with a reduction in pancreatic cancer risk. These associations were represented as adjusted odds ratios (aORs), ranging from 0.620 (95% CI 0.470–0.810) to 0.764 (95% CI 0.655–0.891). Further, age‐stratified analysis revealed variations in efficacy across different age groups. Anticholinergic agents and tertiary amines exhibited greater effectiveness in the 40–64‐year age group (aOR, 0.653; 95% CI, 0.489–0.872), whereas dopa derivatives and dopamine receptor agonists were particularly efficacious in the cohort aged ≥65 years (aOR, 0.728; 95% CI, 0.624–0.850 and aOR, 0.665; 95% CI, 0.494–0.894, respectively). Notably, specific drugs such as trihexyphenidyl, levodopa/dopa decarboxylase inhibitor (DDCI), and pramipexole demonstrated a significant decrease in cancer risk, especially in the elderly population. These preliminary findings can contribute to the possible therapeutic role of anti‐parkinsonian drugs in the treatment of pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
- International Center for Health Information Technology (ICHIT), College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
- Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.
- Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
- Department of Hematology and Oncology, Chang Gung Memorial Hospital at Linkou and College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.
ORCID-Profile: Jason C Hsu, Chih-Wei Huang
Zitieren
APA
Yang, H. C., Chou, W. C., Nguyen, P. A., Nguyen, N. T. H., Phuong, N. T., Wang, C. H., Hsu, J. C., Lin, M. C., & Huang, C. W. (2025). The protective role of anti‐parkinsonian drugs in pancreatic cancer risk: A comprehensive case–control study in Taiwan. Cancer Science. https://doi.org/10.1111/cas.16422
Vancouver
Yang HC, Chou WC, Nguyen PA, Nguyen NTH, Phuong NT, Wang CH, et al. The protective role of anti‐parkinsonian drugs in pancreatic cancer risk: A comprehensive case–control study in Taiwan. Cancer Science. 2025. doi:10.1111/cas.16422
BibTeX
@article{Yang2025,
author = {Yang, Hsuan-Chia and Chou, Wen-Chi and Nguyen, Phung-Anh and Nguyen, Nhi Thi Hong and Phuong, Nguyen Thi and Wang, Ching-Huan and Hsu, Jason C and Lin, Ming-Chin and Huang, Chih-Wei},
title = {The protective role of anti‐parkinsonian drugs in pancreatic cancer risk: A comprehensive case–control study in Taiwan},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.16422}
}
EUVIMED